Evidence map›Paper›PMID 37945752›Full record

ArticleNature biomedical engineering2024

Optogenetic stimulation of vagal nerves for enhanced glucose-stimulated insulin secretion and β cell proliferation.

Yohei Kawana, Junta Imai, Yosuke M Morizawa, Yoko Ikoma, Masato Kohata, Hiroshi Komamura, Toshihiro Sato, Tomohito Izumi, Junpei Yamamoto, Akira Endo and 16 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Nature biomedical engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Neural bridging achieves transcutaneous regulation of vagus nerve function and treatment of depressive disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  14. Review
  15. Review
  16. G proteins of the GScience advances · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 4 institutions in 1 country.

Yohei KawanaDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Junta ImaiDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan. imai@med.tohoku.ac.jp.ORCID 0000-0003-4636-5905
Yosuke M MorizawaSuper-network Brain Physiology, Tohoku University Graduate School of Life Sciences, Sendai, Japan.ORCID 0000-0001-8902-3230
Yoko IkomaSuper-network Brain Physiology, Tohoku University Graduate School of Life Sciences, Sendai, Japan.
Masato KohataDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hiroshi KomamuraDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Toshihiro SatoDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tomohito IzumiDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID 0000-0001-6862-9217
Junpei YamamotoDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Akira EndoDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hiroto SugawaraDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Haremaru KuboDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Shinichiro Hosaka
Yuichiro MunakataDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yoichiro AsaiDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Shinjiro KodamaDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kei TakahashiDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID 0000-0001-9167-2336
Keizo KanekoDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.
Shojiro SawadaDivision of Metabolism and Diabetes, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Tetsuya YamadaDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Akira ItoDepartment of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kuniyasu NiizumaDepartment of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID 0000-0001-9282-6499
Teiji TominagaDepartment of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Akihiro YamanakaDepartment of Neuroscience II, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.ORCID 0000-0001-6099-7306
Ko MatsuiSuper-network Brain Physiology, Tohoku University Graduate School of Life Sciences, Sendai, Japan.ORCID 0000-0003-1068-9705
Hideki KatagiriDepartment of Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID 0000-0003-1093-3704
Tohoku University · JPNagoya University · JPTohoku Medical and Pharmaceutical University · JPTokyo Medical and Dental University · JP

Funding

Japan Agency for Medical Research and Development (AMED) 21gm6210002h0004Japan Agency for Medical Research and Development (AMED) JP21gm5010002h0005MEXT | Japan Science and Technology Agency (JST) JPMJMS2023MEXT | Japan Society for the Promotion of Science (JSPS) 20H05694MEXT | Japan Society for the Promotion of Science (JSPS) 20K17525MEXT | Japan Society for the Promotion of Science (JSPS) 22K19303
6 · The paper itself

Abstract

The enhancement of insulin secretion and of the proliferation of pancreatic β cells are promising therapeutic options for diabetes. Signals from the vagal nerve regulate both processes, yet the effectiveness of stimulating the nerve is unclear, owing to a lack of techniques for doing it so selectively and prolongedly. Here we report two optogenetic methods for vagal-nerve stimulation that led to enhanced glucose-stimulated insulin secretion and to β cell proliferation in mice expressing choline acetyltransferase-channelrhodopsin 2. One method involves subdiaphragmatic implantation of an optical fibre for the photostimulation of cholinergic neurons expressing a blue-light-sensitive opsin. The other method, which suppressed streptozotocin-induced hyperglycaemia in the mice, involves the selective activation of vagal fibres by placing blue-light-emitting lanthanide microparticles in the pancreatic ducts of opsin-expressing mice, followed by near-infrared illumination. The two methods show that signals from the vagal nerve, especially from nerve fibres innervating the pancreas, are sufficient to regulate insulin secretion and β cell proliferation.

Indexed as

Cell ProliferationGlucoseInsulinInsulin-Secreting CellsInsulin SecretionOptogeneticsVagus NerveAnimalsCholine O-AcetyltransferaseMaleMiceVagus Nerve StimulationCholine O-AcetyltransferaseGlucoseInsulin

Identifiers

PMID37945752
PMCPMC11310082
OpenAlexW4388523075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.